1-5 of 5
M A Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.

Free
M Engelhardt, P Drullinsky, J Guillem, M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (11): 1931–1941.
Published: 01 November 1997
View articletitled, Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Open the PDF for Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. in another window
Journal Articles

Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.

Free
M Engelhardt, J Albanell, P Drullinsky, W Han, J Guillem, H I Scher, V Reuter, M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (10): 1849–1857.
Published: 01 October 1997
View articletitled, Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Open the PDF for Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. in another window
Journal Articles

Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.

Free
G Dalbagni, W Han, Z F Zhang, C Cordon-Cardo, P Saigo, W R Fair, H Herr, N Kim, M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1593–1598.
Published: 01 September 1997
View articletitled, Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Open the PDF for Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. in another window
Journal Articles

Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.

Free
F Shapiro, T J Yao, C Moskowitz, L Reich, D L Wuest, S Heimfeld, I K McNiece, J Gabrilove, S Nimer, M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1571–1578.
Published: 01 September 1997
View articletitled, Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Open the PDF for Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. in another window
Journal Articles

Hematopoietic reconstruction: new approaches.

Free
M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (1): 3–9.
Published: 01 January 1995
View articletitled, Hematopoietic reconstruction: new approaches.
Open the PDF for Hematopoietic reconstruction: new approaches. in another window